Implementation of a culturally competent APOL1 genetic testing programme into living donor evaluation: A two-site, non-randomised, pre–post trial design

INTRODUCTION: While living donor (LD) kidney transplantation is the optimal treatment for patients with kidney failure, LDs assume a higher risk of future kidney failure themselves. LDs of African ancestry have an even greater risk of kidney failure post-donation than White LDs. Because evidence sug...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Justin D, Agrawal, Akansha, Wicklund, Catherine, Duquette, Debra, Friedewald, John, Rasmussen, Luke V, Gacki-Smith, Jessica, Tandon, S. Darius, Muhammad, Lutfiyya N, Yancy, Clyde W, Dong, Siyuan, Cooper, Matthew, Gilbert, Alexander, Shetty, Aneesha, Gordon, Elisa J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186444/
https://www.ncbi.nlm.nih.gov/pubmed/37188469
http://dx.doi.org/10.1136/bmjopen-2022-067657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186444/
https://www.ncbi.nlm.nih.gov/pubmed/37188469
http://dx.doi.org/10.1136/bmjopen-2022-067657

Ejemplares similares